Comparison of risedronate versus placebo in preventing anastrozole-induced bone loss in women at high risk of developing breast cancer with osteopenia
View/ Open
Volume
124
Pagination
83 - 88
DOI
10.1016/j.bone.2019.04.016
Journal
BONE
ISSN
8756-3282
Metadata
Show full item recordAuthors
Sestak, I; Blake, GM; Patel, R; Coleman, RE; Cuzick, J; Eastell, RCollections
- Centre for Cancer Prevention [1181]